ERCP and LC for Cholecystocholedocholithiasis in Children: Should It Be Accomplished in One or Repeated Hospitalization?
Endoscopic Retrograde Cholangiopancreatography and Laparoscopic Cholecystectomy for Cholecystocholedocholithiasis in Children: Should It Be Accomplished in One or Repeated Hospitalization?
1 other identifier
observational
25
1 country
1
Brief Summary
Chronic calculous cholecystitis in pediatric patients leads to choledocholithiasis in about 12% of cases. These patients require removal of stones from the common bile duct. The most common method of cleaning the common bile duct is endoscopic retrograde cholangiopancreatography, and the standard technique for removing the gallbladder is laparoscopic cholecystectomy. There are different approaches to the treatment of this category of patients: laparoscopic common bile duct exploration (LCBDE), laparoendoscopic rendezvous method (LERV) and one-stage LC after ERCP. Given the inflammation of the gallbladder and the inflammatory process in the hepatoduodenal ligament, early laparoscopic cholecystectomy can lead to various intraoperative complications. The aim of this retrospective study is to evaluate the efficacy and safety of endoscopic retrograde cholangiopancreatography, endoscopic sphincterotomy with laparoscopic cholecystectomy in a delayed manner (single or repeated hospitalization).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2024
CompletedFirst Posted
Study publicly available on registry
November 4, 2024
CompletedStudy Start
First participant enrolled
November 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 4, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 5, 2025
CompletedFebruary 7, 2025
February 1, 2025
3 months
October 31, 2024
February 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recurrence of common bile duct stones
The diagnosis of the stone in the common bile duct was made by MRI, CT scan and ultrasound, if confirmed, before performing laparoscopic cholecystectomy.
60 days after ERCP
Secondary Outcomes (10)
Bleeding
30 days after ERCP
Perforation
30 days after ERCP
Bile leak
30 days after ERCP
Acute cholangitis
60 days after ERCP
Bile duct stricture
1 year after ERCP
- +5 more secondary outcomes
Study Arms (2)
ERCP, EST and LC in one hospitalization
ERCP, EST and LC on rehospitalization
Interventions
Initially, ERCP with EST was performed by an endoscopist with the consent of the patient or legal representative. The patients underwent endoscopic procedures using fluoroscopy in the operating room, under general anesthesia. Subsequently, laparoscopic cholecystectomy was performed on a delayed basis, 7 to 15 days after ERCP in a single hospitalization
Eligibility Criteria
children under 18 years of age diagnosed with cholecystocholedocholithiasis
You may qualify if:
- Informed consent from child or legal guardian
- Age 0-18 years
- Acute cholecystitis
- Choledocholithiasis
You may not qualify if:
- Unwillingness or inability to consent to the study
- Previous ERCP or percutaneous transhepatic biliary drainage
- Benign or malignant stricture
- Preoperative comorbidities: gastrointestinal bleeding, severe liver disease, acute and chronic cholangitis, septic shock.
- In combination with Mirizzi syndrome and intrahepatic bile duct stones
- Congenital anomaly of the biliary tract
- Malignant neoplasms
- Acute pancreatitis before the procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky
Moscow, Moscow Oblast, 142636, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Dmitriy А Pyhteev, PhD
Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky
- PRINCIPAL INVESTIGATOR
Leonid M Elin
Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 31, 2024
First Posted
November 4, 2024
Study Start
November 21, 2024
Primary Completion
February 4, 2025
Study Completion
February 5, 2025
Last Updated
February 7, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
A complete dataset can be provided upon reasoned request